medRxiv
Gantenerumab reduces brain amyloid-β proteoforms: Biochemical evaluation in dominantly inherited Alzheimer disease
Preprint: non-randomised trial in peopleAlzheimer's disease
Papers by Paul Delmar
5 results
- AAIC 2025 Abstract
TRONTIER 1 and TRONTIER 2: Pivotal trials of trontinemab in early symptomatic Alzheimer’s disease
Trial in peopleInterventions
- AAIC 2025 Abstract
Beyond A Single Study Visit: Lesson Learned from the AD Clinical Trials
Computational studyInterventions